LOADING

Type to search

Implantology Medically Compromised Patients Supporting Your Practice

Dental Implant Survival and Complication Rate for Patients with Diabetes Mellitus

Share

We may be in the early stages of a good news story. My interview with Dr. Thomas Oates, Professor and Chair of the Department of Advanced Oral Sciences and Therapeutics at the University of Maryland, was about a recent study he co-authored and published in Clinical Implant Dentistry & Related Research journal, titled: Dental Implant Survival and Complication Rate over 2 Years for Individuals with Poorly Controlled Type 2 Diabetes Mellitus.

The study offers hope that diabetic patients could benefit from successful implant treatment without complications. I hope you enjoy the interview! 

Chiraz Guessaier, CDA Oasis Manager

Highlights

Background

Emerging evidence suggests that implant therapy may be a viable option for diabetic individuals with elevated glycemic levels.

Purpose

The purpose of this 2-year observational study was to evaluate survival and clinical complications of dental implants following placement in type 2 diabetes individuals having poor glycemic control.

Materials and Methods

Adult participants (n = 24) with poorly controlled type 2 diabetes (8.0% ≤ HbA1c ≤ 12.0%) received two or more transgingival dental implants. Survival was evaluated after 1 (23 participants, 72 implants) and 2 (20 participants, 59 implants) years. Clinical complications were evaluated in 18 participants (52 implants) after 21-34 months. Relationships between complications and stratified HbA1c levels were assessed using Pearson’s correlation test.

Results

Survival rates were 98.6% (71/72 implants) after 1 year and 96.6% (57/59 implants) after 2 years. Complications were identified in 29% of participants with peri-implant mucositis, the most common event. Complications correlated directly with number of implants across HbA1c strata (0.42, R2 = 0.66). There was no correlation between HbA1c and the occurrences of complications or mucositis.

Conclusions

This 2-year evaluation supports the broader application of implant therapy in type 2 diabetes individuals with poor glycemic control in demonstrating high survival rates with limited complications.

 

Full Interview ( 20.47″)

 

1 Comments

  1. Murray Arlin August 12, 2017

    These results need to be supported or challenged with controlled studies with a much longer follow up and studies that have larger sample sizes.

    Reply

Leave a Comment

Your email address will not be published.

%d bloggers like this: